Bayer AG Acquisitions and Exits, 23 Deals Between 1999 and 2019
life science Company

Bayer AG has acquired 13 companies, including 5 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 11 assets.

Bayer AG’s largest acquisition to date was in 2016, when it acquired Monsanto for $66.0B. It’s largest disclosed sale occurred in 2006, when it sold H.C. Starck to The Carlyle Group for $1.3B. Bayer AG has acquired in 4 different US states, and 7 countries. The Company’s most targeted sectors include life science (34%) and medical products (25%).

Join Mergr and gain access to Bayer AG’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

Bayer AG

Kaiser-Wilhelm-Allee 1,
Leverkusen, 51368
Germany,
+49 214 301
www.bayer.com

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.

M&A Summary

Buy vs Sell

Year ≤ '14 '15 '16 '17 '18 '19 T
Buy (0.6/yr) # 9 - 2 1 - - 12
vol $4.6B $66.0B $70.6B
Sell (1.2/yr) # 5 3 - 2 - 1 11
vol $2.3B $1.1B $550M $4.0B
  23

Top M&A Advisors

Financial Deals
Sign-up to View
1
Sign-up to View
1
Sign-up to View
1
Legal Deals
Sign-up to View
1
Sign-up to View
1
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Monsanto Co.
$66.0B (2016-09-14)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest H.C. Starck GmbH
$1.3B (2006-11-23)

Life Science M&A - Last 3 Years

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 385 life science companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 2 have acquired more than 10 companies.

The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 21 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Avista Capital Partners with 6 platform acquisitions.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.7K Private Equity Firms
  • 129K M&A Transactions
  • 138K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 36K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.